Authors:
D. Suchy Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, PL 40752, Katowice, Poland

Search for other papers by D. Suchy in
Current site
Google Scholar
PubMed
Close
,
K. Łabuzek Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, PL 40752, Katowice, Poland

Search for other papers by K. Łabuzek in
Current site
Google Scholar
PubMed
Close
,
O. Pierzchała Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, PL 40752, Katowice, Poland

Search for other papers by O. Pierzchała in
Current site
Google Scholar
PubMed
Close
, and
B. Okopień Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, PL 40752, Katowice, Poland

Search for other papers by B. Okopień in
Current site
Google Scholar
PubMed
Close
Open access

Summary

Ezetimibe is the first in a new class of antihypercholesterolemic drugs. Since it has not long been available on the market, many of its properties may still be revealed. Analytical methods for its determination are scarce, especially regarding serum samples. A simple, fast, and effective high-performance liquid chromatography-ultraviolet (HPLC-UV) method for the determination of ezetimibe concentration in human serum has therefore been developed. Three mobile phases were analysed, and original modifications to the concentration and flow parameters were made. Of five potential internal standards (IS), only nitrendipine was found to be suitable. The analytical wavelength was chosen based on the absorption spectrum of ezetimibe in the mobile phase. Finally, an extraction analysis was performed using two different solvents, and the extrahent volume was optimised. The final method developed was as follows. Single extraction of 1 mL serum sample, spiked with IS, was performed using 10 mL of methyl-t-butyl ether. Separation was obtained at ambient temperature on a Waters C18 Symmetry Shield (4.6 mm × 250 mm, 5 μm) column. The isocratic mobile phase was composed of acetonitrile and 0.1 M ammonium acetate aqueous solution 55:45 (v/v), set at flow rate of 0.75 mL min−1. Ezetimibe was detected at a wavelength of 232 nm after 5.49 min, and the IS was detected at 8.05 min. The developed method has been validated according to ICH standards. It was found to be specific, precise, accurate and linear over the range 10–800 ng mL−1 with R2 > 0.998, and detection and quantification limits of 4.60 ng mL−1 and 13.94 ng mL−1, respectively. The method has been applied to clinical serum samples. The developed technique allowed for successful in vivo assessment of ezetimibe concentrations in samples obtained from hypercholesterolemia patients who are chronically receiving the drug.

  • [1]. L. Jeu J.W. Cheng 2003 Clin. Ther. 25 2352.

  • [2]. M. Garcia-Calvo J. Lisnock H.G. Bull B.E. Hawes D.A. Burnett M.P. Braun J.H. Crona H.R. Davis Jr. D.C. Dean P.A. Detmers M.P. Graziano M. Hughes D.E. Macintyre A. Ogawa K.A. O'neill S.P. Iyer D.E. Shevell M.M. Smith Y.S. Tang A.M. Makarewicz F. Ujjainwalla S.W. Altmann K.T. Chapman N.A. Thornberry 2005 Proc. Natl. Acad. Sci. USA 102 8132.

    • Search Google Scholar
    • Export Citation
  • [3]. H.M. Lotfy A.M. Aboul Alamein M.A. Hegazy 2010 J. AOAC Int. 93 1844.

  • [4]. S.J. Varghese T.K. Ravi 2010 J. AOAC Int. 93 1222.

  • [5]. G. Bahrami B. Mohammadi P.M. Khatabi M.H. Farzaei M.B. Majnooni S.R. Bahoosh 2010 J. Chromatogr. B 878 2789.

  • [6]. R. Sistla V.S. Tata Y.V. Kashyap D. Chandrasekar P.V. Diwan 2005 J. Pharm. Biomed. Anal. 39 517.

  • [7]. S.J. Basha S.A. Naveed N.K. Tiwari D. Shashikumar S. Muzeeb T.R. Kumar N.V. Kumar N.P. Rao N. Srinivas R. Mullangi N.R. Srinivas 2007 J. Chromatogr. B 853 88.

    • Search Google Scholar
    • Export Citation
  • [8]. J.E. Patrick T. Kosoglou K.L. Stauber K.B. Alton S.E. Maxwell Y. Zhu P. Statkevich R. Iannucci S. Chowdhury M. Affrime M.N. Cayen 2002 Drug Metab. Dispos. 30 430.

    • Search Google Scholar
    • Export Citation
  • [9]. M. Hefnawy M. Al-Omar S. Julkhuf 2009 J. Pharm. Biomed. Anal. 50 527.

  • [10]. R.P. Dixit C.R. Barhate S.G. Padhye C.L. Viswanathan M.S. Nagarsenker 2010 Indian J. Pharm. Sci. 72 204.

  • [11]. T. Kosoglou P. Statkevich A.O. Johnson-Levonas J.F. Paolini A.J. Bergman K.B. Alton 2005 Clin. Pharmacokinet. 44 467.

  • [12]. F.J. Al Badarin I.J. Kullo S.L. Kopecky R.J. Thomas 2009 Mayo Clin. Proc. 84 353.

  • [13]. U. Seedorf T. Engel A. Lueken G. Bode S. Lorkowski G. Assmann 2004 Biochem. Biophys. Res. Commun. 320 1337.

  • [14]. S.M. Shaw O. Najam U. Khan N. Yonan S.G. Williams J.E. Fildes 2009 Transpl. Immunol. 21 179.

  • [15]. E. Orsó T. Werner Z. Wolf S. Bandulik W. Kramer G. Schmitz 2006 Cytometry A 69 206.

  • [16]. ICH Expert Working Group, in: ICH Harmonised Triptate Guideline, Geneva, 2005, p. 1.

  • [17]. K. Łabuzek D. Suchy B. Gabryel A. Bielecka S. Liber B. Okopień 2010 Pharmacol. Rep. 62 956.

  • [18]. A.A. Kadav D.N. Vora 2008 J. Pharm. Biomed. Anal. 48 120.

  • [19]. I. Niopas A.C. Daftsios 2003 J. Pharm. Biomed. Anal. 32 1213.

  • [20]. B.G. Chaudhari N.M. Patel P.B. Shah L.J. Patel V.P. Patel 2007 J. AOAC Int. 90 1539.

  • [21]. S. Oswald E. Scheuch I. Cascorbi W. Siegmund 2006 J. Chromatogr. B 830 143.

  • [22]. S. Li G. Liu J. Jia X. Li C. Yu 2006 J. Pharm. Biomed. Anal. 40 987.

  • [23]. C. Simard J. Turgeon 2003 Can. J. Clin. Pharmacol. 10SupplA 13A.

  • [24]. A.K. Gajjar V.D. Shah 2011 J. Pharm. Biomed. Anal. 55 225.

  • [25]. F. Ezzet G. Krishna D.B. Wexler P. Statkevich T. Kosoglou V.K. Batra 2001 Clin. Ther. 23 871.

  • Collapse
  • Expand
The author instruction is available in PDF.
Please, download the file from HERE.
 
The Open Access statement together with the description of the Copyright and License Policy are available in PDF.
Please, download the file from HERE.
 

 

Senior editors

Editor(s)-in-Chief: Kowalska, Teresa (1946-2023)

Editor(s)-in-Chief: Sajewicz, Mieczyslaw

Editors(s)

  • Danica Agbaba (University of Belgrade, Belgrade, Serbia)
  • Łukasz Komsta (Medical University of Lublin, Lublin, Poland)
  • Ivana Stanimirova-Daszykowska (University of Silesia, Katowice, Poland)
  • Monika Waksmundzka-Hajnos (Medical University of Lublin, Lublin, Poland)

Editorial Board

  • R. Bhushan (The Indian Institute of Technology, Roorkee, India)
  • J. Bojarski (Jagiellonian University, Kraków, Poland)
  • B. Chankvetadze (State University of Tbilisi, Tbilisi, Georgia)
  • M. Daszykowski (University of Silesia, Katowice, Poland)
  • T.H. Dzido (Medical University of Lublin, Lublin, Poland)
  • A. Felinger (University of Pécs, Pécs, Hungary)
  • K. Glowniak (Medical University of Lublin, Lublin, Poland)
  • B. Glód (Siedlce University of Natural Sciences and Humanities, Siedlce, Poland)
  • A. Gumieniczek (Medical University of Lublin, Lublin, Poland)
  • U. Hubicka (Jagiellonian University, Kraków, Poland)
  • K. Kaczmarski (Rzeszow University of Technology, Rzeszów, Poland)
  • H. Kalász (Semmelweis University, Budapest, Hungary)
  • K. Karljiković Rajić (University of Belgrade, Belgrade, Serbia)
  • I. Klebovich (Semmelweis University, Budapest, Hungary)
  • A. Koch (Private Pharmacy, Hamburg, Germany)
  • P. Kus (Univerity of Silesia, Katowice, Poland)
  • D. Mangelings (Free University of Brussels, Brussels, Belgium)
  • E. Mincsovics (Corvinus University of Budapest, Budapest, Hungary)
  • Á. M. Móricz (Centre for Agricultural Research, Budapest, Hungary)
  • G. Morlock (Giessen University, Giessen, Germany)
  • A. Petruczynik (Medical University of Lublin, Lublin, Poland)
  • R. Skibiński (Medical University of Lublin, Lublin, Poland)
  • B. Spangenberg (Offenburg University of Applied Sciences, Germany)
  • T. Tuzimski (Medical University of Lublin, Lublin, Poland)
  • Y. Vander Heyden (Free University of Brussels, Brussels, Belgium)
  • A. Voelkel (Poznań University of Technology, Poznań, Poland)
  • B. Walczak (University of Silesia, Katowice, Poland)
  • W. Wasiak (Adam Mickiewicz University, Poznań, Poland)
  • I.G. Zenkevich (St. Petersburg State University, St. Petersburg, Russian Federation)

 

KOWALSKA, TERESA (1946-2023)
E-mail: kowalska@us.edu.pl

SAJEWICZ, MIECZYSLAW
E-mail:msajewic@us.edu.pl

Indexing and Abstracting Services:

  • Science Citation Index
  • Sci Search
  • Research Alert
  • Chemistry Citation Index and Current Content/Physical
  • Chemical and Earth Sciences
  • SCOPUS
  • GoogleScholar
  • Index Copernicus
  • CABI
  • CABELLS Journalytics

2022  
Web of Science  
Total Cites
WoS
647
Journal Impact Factor 1.9
Rank by Impact Factor

Chemistry, Analytical (Q3)

Impact Factor
without
Journal Self Cites
1.9
5 Year
Impact Factor
1.4
Journal Citation Indicator 0.41
Rank by Journal Citation Indicator

Chemistry, Analytical (Q3)

Scimago  
Scimago
H-index
29
Scimago
Journal Rank
0.28
Scimago Quartile Score

Chemistry (miscellaneous) (Q3)

Scopus  
Scopus
Cite Score
3.1
Scopus
CIte Score Rank
General Chemistry 211/407 (48th PCTL)
Scopus
SNIP
0.549

2021  
Web of Science  
Total Cites
WoS
652
Journal Impact Factor 2,011
Rank by Impact Factor Chemistry, Analytical 66/87
Impact Factor
without
Journal Self Cites
1,789
5 Year
Impact Factor
1,350
Journal Citation Indicator 0,40
Rank by Journal Citation Indicator Chemistry, Analytical 72/99
Scimago  
Scimago
H-index
29
Scimago
Journal Rank
0,27
Scimago Quartile Score Chemistry (miscellaneous) (Q3)
Scopus  
Scopus
Cite Score
2,8
Scopus
CIte Score Rank
General Chemistry 210/409 (Q3)
Scopus
SNIP
0,586

2020
 
Total Cites
650
WoS
Journal
Impact Factor
1,639
Rank by
Chemistry, Analytical 71/83 (Q4)
Impact Factor
 
Impact Factor
1,412
without
Journal Self Cites
5 Year
1,301
Impact Factor
Journal
0,34
Citation Indicator
 
Rank by Journal
Chemistry, Analytical 75/93 (Q4)
Citation Indicator
 
Citable
45
Items
Total
43
Articles
Total
2
Reviews
Scimago
28
H-index
Scimago
0,316
Journal Rank
Scimago
Chemistry (miscellaneous) Q3
Quartile Score
 
Scopus
393/181=2,2
Scite Score
 
Scopus
General Chemistry 215/398 (Q3)
Scite Score Rank
 
Scopus
0,560
SNIP
 
Days from
58
submission
 
to acceptance
 
Days from
68
acceptance
 
to publication
 
Acceptance
51%
Rate

2019  
Total Cites
WoS
495
Impact Factor 1,418
Impact Factor
without
Journal Self Cites
1,374
5 Year
Impact Factor
0,936
Immediacy
Index
0,460
Citable
Items
50
Total
Articles
50
Total
Reviews
0
Cited
Half-Life
6,2
Citing
Half-Life
8,3
Eigenfactor
Score
0,00048
Article Influence
Score
0,164
% Articles
in
Citable Items
100,00
Normalized
Eigenfactor
0,05895
Average
IF
Percentile
20,349
Scimago
H-index
26
Scimago
Journal Rank
0,255
Scopus
Scite Score
226/167=1,4
Scopus
Scite Score Rank
Chemistry (miscellaneous) 240/398 (Q3)
Scopus
SNIP
0,494
Acceptance
Rate
41%

 

Acta Chromatographica
Publication Model Online only
Gold Open Access
Submission Fee none
Article Processing Charge 400 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Gold Open Access
Purchase per Title  

Acta Chromatographica
Language English
Size A4
Year of
Foundation
1988
Volumes
per Year
1
Issues
per Year
4
Founder Institute of Chemistry, University of Silesia
Founder's
Address
PL-40-007 Katowice, Poland, Bankowa 12
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2083-5736 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2023 0 2 3
May 2023 0 1 2
Jun 2023 0 2 5
Jul 2023 0 1 3
Aug 2023 0 1 1
Sep 2023 0 6 2
Oct 2023 0 0 0